Navigation Links
GeoVax Labs' CEO Update Letter to Shareholders
Date:1/9/2012

ATLANTA, Jan. 9, 2012 /PRNewswire/ -- Robert McNally, Ph.D., President and CEO of GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), today issued the following letter to shareholders:

Dear Fellow Shareholders,

At the start of a new year, it is important to acknowledge all that we have accomplished over the past year, but it is even more crucial to focus our energies on the challenges and opportunities awaiting GeoVax in 2012 and beyond.

Here is a recap of our recent achievements, which have put the company on course for a very successful future. During 2011, GeoVax achieved steady progress in developing our HIV/AIDS vaccines and continued to lay a solid foundation for continued clinical and corporate success. While we are pleased with our results, our goal for 2012 is to achieve even greater and more timely progress.

Therapeutic Vaccine Program

We continue to make progress in our Phase 1/2 clinical trial for our HIV/AIDS therapeutic vaccine. The primary goals of the trial are to document the safety and immunogenicity (e.g., "immune response") of the vaccine in HIV-diagnosed patients with well-controlled infections. To accelerate enrollment in the trial, we added two clinical sites, the University of Alabama, Birmingham and the AIDS Research Alliance in Los Angeles. These sites join our initial site in Atlanta that is being run by ARCA (AIDS Research Consortium of Atlanta). In December, we announced inoculation of the first participant in this clinical program. Our goal is to have full enrollment by the end of 2012 and to be generating meaningful data in 2013. If the data are encouraging, this program will likely be expanded into a larger Phase 2 clinical trial. The successful application of our vaccine among already infected patients would represent a significant addition, and potential alternative, to the current antiviral drug therapy that is required for the remainder of a patient's life. Current estimates of the
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
2. GeoVax Phase 2a Clinical Trial Completes Enrollment
3. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
4. GeoVax Labs, Inc. Announces Second Quarter Financial Results
5. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
6. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
7. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
8. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
9. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
10. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
11. GeoVax Labs Engages The Investor Relations Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014 Decision Resources Group finds that, for ... ( France , Germany ... and the United Kingdom ... once-daily long-acting beta2 agonist/inhaled corticosteroid (LABA/ICS) fixed-dose combination (FDC), ... as a first-line LABA/ICS FDC in the treatment of ...
(Date:7/24/2014)... -- "North America Orthopedic Braces and Supports Market Outlook ... America Orthopedic Braces and Supports market. The report provides ... units) and average price data (in US dollars), within ... , Ankle Braces and Supports , Spinal ... Supports. Photo - http://photos.prnewswire.com/prnh/20140723/129806 ...
(Date:7/24/2014)... BOSTON , July 24, 2014 Boston ... on Tomorrow (#PedInno14), will feature an "Innovation Tank" ... innovators an opportunity to pitch their business or product ... of funding and feedback on how to accelerate the ... competition, occurring the morning of Friday, October 31, will ...
Breaking Medicine Technology:Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 2Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 3
... /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: ... diagnostic ("IVD") company, announced its unaudited financial results for ... FY2010") today. 3Q FY2010 ... 2009December 31, 2010December 31, ...
... Zimmer Holdings, Inc. (NYSE: ZMH ; SIX: ... launch of the PathFinder NXT™ System at the ... San Diego, CA.  The PathFinder NXT System builds ... PathFinder Minimally Invasive Pedicle Screw System to ...
Cached Medicine Technology:China Medical Technologies Reports Third Fiscal Quarter Financial Results 2China Medical Technologies Reports Third Fiscal Quarter Financial Results 3China Medical Technologies Reports Third Fiscal Quarter Financial Results 4China Medical Technologies Reports Third Fiscal Quarter Financial Results 5China Medical Technologies Reports Third Fiscal Quarter Financial Results 6China Medical Technologies Reports Third Fiscal Quarter Financial Results 7China Medical Technologies Reports Third Fiscal Quarter Financial Results 8China Medical Technologies Reports Third Fiscal Quarter Financial Results 9China Medical Technologies Reports Third Fiscal Quarter Financial Results 10China Medical Technologies Reports Third Fiscal Quarter Financial Results 11China Medical Technologies Reports Third Fiscal Quarter Financial Results 12China Medical Technologies Reports Third Fiscal Quarter Financial Results 13China Medical Technologies Reports Third Fiscal Quarter Financial Results 14China Medical Technologies Reports Third Fiscal Quarter Financial Results 15China Medical Technologies Reports Third Fiscal Quarter Financial Results 16China Medical Technologies Reports Third Fiscal Quarter Financial Results 17China Medical Technologies Reports Third Fiscal Quarter Financial Results 18China Medical Technologies Reports Third Fiscal Quarter Financial Results 19China Medical Technologies Reports Third Fiscal Quarter Financial Results 20China Medical Technologies Reports Third Fiscal Quarter Financial Results 21China Medical Technologies Reports Third Fiscal Quarter Financial Results 22Zimmer Launches PathFinder NXT™ Minimally Invasive Pedicle Screw System 2Zimmer Launches PathFinder NXT™ Minimally Invasive Pedicle Screw System 3
(Date:7/24/2014)... July 25, 2014 The report, ... the CDN market into various sub-segments with an ... identifies the drivers and restraints for this market ... Browse 93 market data tables and 36 figures ... “Content Delivery Networks (CDN) Market” at http://www.marketsandmarkets.com/Market-Reports/content-delivery-networks-cdn-market-657.html ...
(Date:7/24/2014)... HealthDay Reporter THURSDAY, July 24, 2014 (HealthDay ... dead wrong, according to a small study that asked boys what ... boys between the ages of 14 and 16, researchers found that ... closeness and trust. Very few boasted about sexual conquests or saw ... girl. "In our culture, we have lots of assumptions about ...
(Date:7/24/2014)... RI (PRWEB) July 24, 2014 Pools and ... But the water can be dangerous, especially for small children, ... promote water safety. , According to the Centers for Disease ... 4 are most at risk for water-related injuries and deaths. ... children safe around water, so Amica is offering the following ...
(Date:7/24/2014)... (HealthDay News) -- Drinking caffeine may worsen the hot ... women as they go through menopause, new survey data ... suggests that limiting caffeine intake may be useful for ... night sweats," said researcher Dr. Stephanie Faubion, director of ... Rochester, Minn. But caffeine -- a stimulant found ...
(Date:7/24/2014)... Horizon BCBSNJ’s second annual “Back to ... a rent-free week in a beautiful Lavallette shore house, ... miss your chance to win a week’s vacation at ... New Jersey residents, 25 or older.* Residents can enter ... . , “A family vacation at the Jersey ...
Breaking Medicine News(10 mins):Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 2Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 3Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:(Beach) Sands of Time Running out to Enter Horizon Blue Cross Blue Shield of New Jersey’s 2014 “Back to the Boardwalk” Sweepstakes 2
... in year-end KLAS survey, PITTSBURGH, Jan. 10 ... by major healthcare providers who,use automated patient flow ... The ranking was listed in the KLAS 2007 ... thousands of healthcare professionals of,health information technology vendors ...
... Clients Suffering from Smoking-Related Illnesses Fight Back against Big ... ... trial attorney, Willie,Gary, along with partners, CK Hoffler, Donald Watson and ... Watson and,Sperando, P.L. announced today that the firm will be representing ...
... climate change was a leading topic of interest for ... two stories that portrayed significantly different messages about the ... Stories in 2007 were identified by monitoring Web site ... highest total number of visits between January and December ...
... at The University of Texas Health Science Center at ... human saliva to provide an early, non-invasive diagnosis of ... Jan. 10, 2008 issue of the journal "Cancer Investigation." ... cancer produces a change in the normal type and ...
... care quality evaluator determines programs improve ... ... Health,Solutions, Inc., (NYSE: MHS ) today announced that it has ... member engagement programs that improve pharmacy care and,prescription drug safety. The ...
... discovery company builds strong financial and clinical foundation, in preparation for ... ... for diabetes, EMERYVILLE, Calif., Jan. 10 ... in its drive to,release Tethys Diabetes PreDxTM, a multi-biomarker technology that ...
Cached Medicine News:Health News:KLAS Ranks TeleTracking Bed Management Suite No. 1 2Health News:Famed Attorney Willie Gary Files $10.6 Billion in Lawsuits against Big Tobacco Companies on Behalf of Florida Smokers and their Families 2Health News:Climate change, gender differences, health among EurekAlert! 10 Most Popular Stories in 2007 2Health News:Climate change, gender differences, health among EurekAlert! 10 Most Popular Stories in 2007 3Health News:Climate change, gender differences, health among EurekAlert! 10 Most Popular Stories in 2007 4Health News:Climate change, gender differences, health among EurekAlert! 10 Most Popular Stories in 2007 5Health News:Climate change, gender differences, health among EurekAlert! 10 Most Popular Stories in 2007 6Health News:UT Health Science Center researchers decoding saliva to detect breast cancer 2Health News:UT Health Science Center researchers decoding saliva to detect breast cancer 3Health News:Medco's Specialized Pharmacists, Safety Programs Gain Therapy Management Accreditation 2Health News:Medco's Specialized Pharmacists, Safety Programs Gain Therapy Management Accreditation 3Health News:Medco's Specialized Pharmacists, Safety Programs Gain Therapy Management Accreditation 4Health News:Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory 2Health News:Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory 3
Single Use Loading Units with Titanium Staples for use with Powered MULTIFIRE ENDO GIA™ 60 (15 mm Single Use Stapler with Titanium Staples)....
Providing maximum versatility and maneuverability, the Articulator 35 is the only stapler for use in endoscopic and open procures that provides greater access to targeted structures with limited oper...
Improved Access in Open Procedures with Compact Endoscopic Linear Cutters., ,Staplers may be reloaded seven times for a total of eight firings. Different cartridges of the same size can be interchan...
... ETS45 and ETS-FLEX45 Endoscopic Linear ... and cut line. The 34cm ... suitable for many minimally invasive ... intended for transection, resection, and/or ...
Medicine Products: